House Approves Bill Easing Imports of Less Expensive Drugs
By SHERYL GAY STOLBERG
[]ASHINGTON, July 25 -- In a major defeat for the pharmaceutical industry, the House voted by a wide margin early this morning to approve a measure that would make it easier for Americans to import inexpensive prescription medicines from Canada and Europe.
The vote, 243-186, came shortly before 3 a.m., after a fiery hour-long debate that capped a long and stressful day for lawmakers, who are rushing to finish their business by tonight so they can leave the Capitol to start their month-long summer recess.
The outcome was a surprise. Until the last minute, lawmakers on both sides were saying the vote would be too close to call. Even as the votes were being cast, some lawmakers held back, to see which way their colleagues were voting.
"I think this is the Congress saying, ‘We hear you, drug prices are too high," said Representative Jo Ann H. Emerson, Republican of Missouri, who forced the vote by extracting a promise from the House leadership in exchange for favoring a broader Medicare prescription drug benefit that is a high priority of the White House. She added, "It's time we stopped subsidizing the world and bring fairness and fair prices to Americans."
This statement says it all ""The issue is not safety, my friends," said Representative Rosa DeLauro, Democrat of Connecticut. "The issue is price. It is time that this Congress stop acting as a wholly-owned subsidiary of the pharmaceutical companies and step up to its responsibility to the consumers of this nation."
http://www.nytimes.com/2003/07/25/politics/25DRUG.html?th